Principal Financial Group Inc Cor Medix Inc. Transaction History

Principal Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$4.08 - $6.39 $41,734 - $65,363	10,229 New	10,229 $44,000
Q2 2020 Aug 05, 2020	SELL	$3.08 - $6.56 $60,749 - $129,389	-19,724 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$2.35 - $7.08 $157 - $474	67 Added 0.34%	19,724 $71,000
Q4 2019 Feb 05, 2020	SELL	$4.96 - $7.75 $34,412 - $53,769	-6,938 Reduced 26.09%	19,657 $143,000
Q3 2019 Nov 13, 2019	BUY	$6.38 - $9.69 $1,199 - $1,821	188 Added 0.71%	26,595 $170,000
Q2 2019 Aug 12, 2019	BUY	$5.93 - $10.57 $156,593 - $279,121	26,407 New	26,407 $237,000

120

18.3M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $405M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.